BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 1, 2000
View Archived Issues
Aminobisphosphonates activate T-cells against multiple myeloma
Read More
Cancer gene therapy with fusion molecule induces potent, selective apoptosis
Read More
Hemolink receives priority review in Canada
Read More
Myocardial gene transfer restores function to ischemic heart areas
Read More
Potent HIV protease inhibitor shows potential for use in combination therapy
Read More
GAR-936 inhibits resistant Gram-positive bacteria
Read More
Neutrophil elastase inhibitors may actually target an important host defense enzyme
Read More
Circulation rapidly restored in limbs of diabetic mice by exogenous angioblasts
Read More
Visudyne sNDA granted priority review status
Read More
THC derivative demonstrates safety, lack of marijuana-like effects in phase I trial
Read More
Alexion completes enrollment of 5G1.1 phase II study, begins open-label extension study
Read More
Novogen's lead anticancer compound continues to advance in clinical trials
Read More
Avant Immunotherapeutics obtains patent license for oral typhoid vaccine
Read More
BioSante signs license option with Antex Biologics for vaccine technology
Read More
Abbott develops potential new compounds for incontinence therapy
Read More
RXR-selective ligands offer approach to tamoxifen-resistant tumors
Read More
Magainin awarded SBIR Grant for development of asthma therapy
Read More
Viragen and Zonagen to study topical genital herpes treatment; Zonagen awarded SBIR grant
Read More
Pharmacia and Recordati collaborate on potential overactive bladder treatments
Read More
Matrix metalloproteinase inhibitors reported by Fujisawa
Read More
New series of factor Xa inhibitors claimed by Aventis
Read More
Kotobuki describes new series of cholesterol biosynthesis inhibitors
Read More
Alizyme presents new lipase inhibitors
Read More
Vascular damaging agents reported by Angiogene
Read More
New compounds interacting with CB2 receptors described by Japan Tobacco
Read More
CCR-5 receptor modulators reportedly useful for HIV infection
Read More